A detailed history of Tsfg, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Tsfg, LLC holds 300 shares of HBIO stock, worth $642. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Previous 300 -0.0%
Holding current value
$642
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023

SELL
$2.45 - $4.22 $490 - $844
-200 Reduced 40.0%
300 $1,000
Q2 2021

Jul 19, 2021

BUY
$5.44 - $8.4 $1,088 - $1,680
200 Added 66.67%
500 $4,000
Q1 2019

Jan 27, 2020

BUY
$2.77 - $4.38 $831 - $1,314
300 New
300 $1,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Tsfg, LLC Portfolio

Follow Tsfg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsfg, LLC with notifications on news.